Point-Of-Care Manufacturing Successfully Treats B-Cell Cancers; How Will FDA Regulate It?

Point-of-care manufacturing successfully used to manufacture T-cells for cancer treatment • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Manufacturing

More from Compliance